Company
Endogena
is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs.
Also known as Endogena Therapeutics
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs. Our approach has the potential of a paradigm shift to treat degenerative conditions related to aging and genetic disorders.
Funding snapshot
- Total raised
- $15.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $7.3M2021-11-04
Funding rounds
- Round, 2021
- $7.3M2021-11-04, SEC form D sold, 12 investors
- Round, 2020
- $8M2020-12-21, SEC form D sold, 13 investors
Products
- Other
- EA-2353
Loading relationship preview